Camila Maria Longo Machado

She is currently the CEO of i.rad.Particles, with joint projects expanding Research and Development with Columbia University and MSKCC-New York. She was a Scientific Researcher at LIM43 Radioisotopes Medical Investigation Laboratory of HC-FMUSP, component of CIBio-ICESP, EEP. She is an occasional collaborating professor at UFJF and a Researcher at the Translational Oncology Center of the Sao Paulo Cancer Institute - ICESP. She maintains collaborations with Grimm-Lab-NY-MSKCC to this day in the areas of biomaterials and Cancer biology. She works in biotechnology and molecular imaging, focusing on: fluorescence, optoacoustics (RSOM), and micro-PET-SPECT-CT at ICESP and Nuclear Medicine Center-Inrad/HCFMUSP. Additionally, she researches biological phenomena associated with extracellular vesicles and "Membrane particles," especially in prostate cancer. She holds a degree in Biological Sciences, Medical Modality from UNICAMP (2000), master's (2004), and Ph.D. in Genetics and Molecular Biology from the State University of Campinas (emphasis on immunology 2008, rated 7 by Capes). She had clinical experience as a technologist/biomedical scientist in Nuclear Medicine at UNICAMP's HC Nuclear Medicine Service. At the USP Medical School, she did her first postdoctoral work in Oncology (Prof. Roger Chammas), and as a Scientific Researcher, she did postdoctoral work at the Memorial Sloan-Kettering Cancer Center to determine the physiological role of PSMA in tumor angiogenesis using molecular imaging. (Source: Lattes Curriculum)